
Marshall Wace’s CorMedix CRMD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $31.8M | Buy |
2,579,976
+2,349,451
| +1,019% | +$28.9M | 0.04% | 382 |
|
2025
Q1 | $1.42M | Buy |
+230,525
| New | +$1.42M | ﹤0.01% | 1525 |
|
2024
Q4 | – | Sell |
-161,755
| Closed | -$1.31M | – | 2443 |
|
2024
Q3 | $1.31M | Buy |
161,755
+9,480
| +6% | +$76.6K | ﹤0.01% | 1416 |
|
2024
Q2 | $659K | Buy |
152,275
+79,619
| +110% | +$345K | ﹤0.01% | 1686 |
|
2024
Q1 | $308K | Sell |
72,656
-390,350
| -84% | -$1.66M | ﹤0.01% | 1844 |
|
2023
Q4 | $1.74M | Sell |
463,006
-451,163
| -49% | -$1.7M | ﹤0.01% | 1058 |
|
2023
Q3 | $3.38M | Sell |
914,169
-524,709
| -36% | -$1.94M | 0.01% | 893 |
|
2023
Q2 | $5.7M | Buy |
1,438,878
+1,237,479
| +614% | +$4.9M | 0.01% | 826 |
|
2023
Q1 | $834K | Buy |
201,399
+48,024
| +31% | +$199K | ﹤0.01% | 1483 |
|
2022
Q4 | $647K | Buy |
153,375
+110,298
| +256% | +$465K | ﹤0.01% | 1728 |
|
2022
Q3 | $122K | Sell |
43,077
-101,114
| -70% | -$286K | ﹤0.01% | 2404 |
|
2022
Q2 | $579K | Buy |
144,191
+110,536
| +328% | +$444K | ﹤0.01% | 2094 |
|
2022
Q1 | $184K | Buy |
+33,655
| New | +$184K | ﹤0.01% | 2408 |
|
2019
Q4 | – | Sell |
-4,552
| Closed | -$29K | – | 1701 |
|
2019
Q3 | $29K | Buy |
+4,552
| New | +$29K | ﹤0.01% | 1525 |
|